![Bittoo Kanwar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bittoo Kanwar
Keine laufenden Positionen mehr
Profil
Bittoo Kanwar formerly worked at Ensho Therapeutics, Inc., as Chief Executive Officer, Protagonist Therapeutics, Inc., as Vice President-Clinical Development, and Applied Molecular Transport, Inc., as Chief Medical Officer from 2019 to 2023.
Dr. Kanwar received his graduate degree from the University of Iowa.
Ehemalige bekannte Positionen von Bittoo Kanwar
| Unternehmen | Position | Ende |
|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.03.2023 |
| PROTAGONIST THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Bittoo Kanwar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Applied Molecular Transport, Inc.
 Applied Molecular Transport, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that designs and develops novel oral biologic products | Commercial Services |
